Robuta

https://www.globenewswire.com/news-release/2025/04/03/3055091/0/en/Enlivex-Announces-the-Dosing-of-the-First-Patient-in-a-Phase-I-Trial-Evaluating-Allocetra-in-Patients-with-TMJ-Osteoarthritis.html Enlivex Announces the Dosing of the First Patient in a Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition... first patientannouncesdosing https://www.globenewswire.com/news-release/2018/10/25/1626784/0/en/Axovant-Announces-Dosing-of-First-Patient-in-Clinical-Study-of-AXO-Lenti-PD-a-Novel-Gene-Therapy-for-Patients-With-Parkinson-s-Disease.html Axovant Announces Dosing of First Patient in Clinical Study Initial data from the first cohort expected in first half of 2019 BASEL, Switzerland, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON),... first patientaxovantannouncesdosingclinical https://patientportaldemo.mpmfirst.com/ MPM First - Patient Portal Demo first patientmpmportaldemo https://www.biospace.com/press-releases/braintale-announces-first-patient-enrolled-in-investigator-sponsored-prospective-multi-centric-study-caldiff-to-clinically-validate-one-of-its-predictive-biomarkers BrainTale Announces First Patient Enrolled in Investigator-Sponsored Prospective Multi-Centric... first patientannouncesenrolled https://www.biospace.com/press-releases/vanda-pharmaceuticals-announces-first-patient-dosed-in-a-trial-evaluating-vca-894a-in-charcot-marie-tooth-disease-type-2s Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in... first patient https://www.healthday.com/health-news/public-health/cdc-confirms-first-patient-diagnosed-with-ebola-in-united-states-692236.html CDC Confirms First Patient Diagnosed With Ebola in United States Unidentified man at Dallas hospital developed symptoms days after flying from West Africa first patientcdcconfirmsdiagnosedebola https://www.businesswire.com/news/home/20220607005182/en/AtriCure-Announces-the-First-Patient-Treated-in-the-HEAL-IST-Clinical-Trial AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... the firsttreated inannouncespatient https://www.finanznachrichten.de/nachrichten-2025-06/65595727-kazia-therapeutics-limited-kazia-therapeutics-announces-first-patient-dosed-in-phase-1b-trial-of-paxalisib-in-advanced-breast-cancer-008.htm Kazia Therapeutics Limited: Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of... Trial is expected to provide key insights on how paxalisib therapy can be combined with established immunotherapies and standard of care chemotherapy to... kazia therapeutics limitedfirst patient https://www.prnewswire.com/news-releases/endo-announces-first-patient-enrolled-in-registry-of-dupuytrens-contracture-301861246.html Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in GRASP-DC (Generating Real-world Ambispective... first patientin registryendoannouncesenrolled https://www.globenewswire.com/news-release/2020/11/09/2122648/0/en/Intellia-Therapeutics-Doses-First-Patient-in-Landmark-CRISPR-Cas9-Clinical-Trial-of-NTLA-2001-for-the-Treatment-of-Transthyretin-Amyloidosis.html Intellia Therapeutics Doses First Patient in Landmark NTLA-2001: First single-course therapy that potentially halts and reverses ATTR progression First-ever in vivo CRISPR treatment delivered intravenously to... intellia therapeuticsfirst patientdoseslandmark https://www.globenewswire.com/news-release/2025/06/12/3098051/0/en/SNIPR-BIOME-Announces-First-Patient-Dosed-in-its-Phase-1b-Clinical-Trial-of-SNIPR001-in-Patients-with-Hematological-Cancer.html SNIPR BIOME Announces First Patient Dosed in its Phase 1b SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer.... first patientbiomeannouncesdosedphase https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-first-patient-dosed-in-a-trial-evaluating-vca-894a-in-charcot-marie-tooth-disease-type-2s-302477600.html Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in... /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in the first-in-human clinical trial to evaluate the safety... first patient https://www.biospace.com/cognito-therapeutics-announces-first-patient-enrolled-in-hope-biomarker-study Cognito Therapeutics Announces First Patient Enrolled in HOPE Biomarker Study - BioSpace Jan 23, 2024 - Cognito Therapeutics announced today the first patient enrolled in a biomarker substudy within the HOPE pivotal trial . first patientcognitotherapeuticsannounces https://www.brusselstimes.com/belgium/99600/coronavirus-congo-confirms-first-patient-is-belgian-citizen/ Coronavirus: First patient in Congo is Belgian citizen first patientcoronaviruscongobelgiancitizen https://www.aoa.org/news/practice-management/perfect-your-practice/aoa-more-reports-first-patient-data_helps-mips-providers-attest AOA MORE reports first patient data, helps MIPS providers attest | AOA AOA MORE's first release of patient aggregate data shows optometry is letting the data speak for itself; more than 1.2 million patients and 650,000 patient... aoa morefirst patientreportsdatahelps https://www.globenewswire.com/news-release/2026/04/28/3282578/0/en/kestrel-therapeutics-announces-first-patient-dosed-in-the-phase-1-clinical-trial-of-kst-6051-a-potential-best-in-class-pan-kras-inhibitor-in-patients-with-kras-driven-malignancies.html?_gl=1*oxw2al*_up*MQ..*_ga*MTI3NTk2NTA3My4xNzc3Mzc3NzEx*_ga_B6167QB2TF*czE3NzczNzc3MTAkbzEkZzAkdDE3NzczNzc3MTAkajYwJGwwJGgw*_ga_ERWPGTJ5X8*czE3NzczNzc3MTEkbzEkZzAkdDE3NzczNzc3MTEkajYwJGwwJGgw Kestrel Therapeutics Announces First Patient Dosed in the Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based on defined development... first patientkestreltherapeuticsannouncesdosed https://www.prweb.com/releases/lipella_pharmaceuticals_announces_enrollment_of_first_patient_in_phase_2_trial_in_interstitial_cystitis/prweb12924608.htm Lipella Pharmaceuticals Announces Enrollment of First Patient in Phase-2 Trial in Interstitial... Pittsburgh, PA (PRWEB) August 27, 2015 -- Lipella Pharmaceuticals Inc. today announced dose administration for the first patient in a Phase-2 clinical study... phase 2 trialfirst patient https://www.businesswire.com/news/home/20250107423425/en/Diality-Announces-First-Patient-Treated-With-Moda-flx-Hemodialysis-System Diality Announces First Patient Treated With Moda-flx Hemodialysis System Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced successful completion of the first-ever patient treatme... first patientannouncestreatedmodaflx https://www.biospace.com/xeris-pharmaceuticals-doses-first-patient-in-phase-2-trial-evaluating-its-developmental-ready-to-use-glucagon-in-patients-at-risk-from-hypoglycemia-following-bariatric-surgery Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Developmental... Jun 27, 2019 - Xeris Pharmaceuticals, Inc. announced that is has dosed the first subject in a Phase 2 trial with its developmental ready-to-use glucagon in patients who... phase 2 trialxeris pharmaceuticalsfirst patient https://www.mdanderson.org/cancerwise/meet-md-anderson-proton-therapy-centers-first-patient.h00-158987445.html Meet MD Anderson Proton Therapy Center's first patient | UT MD Anderson Frank Bauer wasn't looking to be a trailblazer when he made an appointment at the MD Anderson Proton Therapy Center nine years ago. He just wanted the best... md andersonproton therapyfirst patientmeetcenter https://www.businesswire.com/news/home/20260205463523/en/Magnus-Medical-Announces-First-Patient-Enrolled-at-University-of-Massachusetts-in-Pivotal-DoD-Funded-Multisite-Study-of-SAINT-for-Postpartum-Depression Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal... Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision medicine in brain health, today announced enrollment of the first ... university of massachusettsfirst patient https://www.gutenberg.org/ebooks/22883 Doctor Luttrell's First Patient by Rosa Nouchette Carey | Project Gutenberg Free eBook digitized and proofread by volunteers. rosa nouchette careyfirst patientdoctorluttrell https://www.globenewswire.com/news-release/2024/06/18/2900276/0/en/Immunocore-announces-randomization-of-first-patient-in-the-global-registrational-Phase-3-clinical-trial-testing-brenetafusp-for-the-treatment-of-first-line-advanced-or-metastatic-c.html Immunocore announces randomization of first patient in the Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of... first patientimmunocoreannouncesrandomization https://www.finanznachrichten.de/nachrichten-2026-03/68033916-c4-therapeutics-inc-c4-therapeutics-announces-first-patient-dosed-in-phase-1b-trial-of-cemsidomide-in-combination-with-elranatamab-elrexfio-for-r-399.htm C4 Therapeutics, Inc.: C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of... WATERTOWN, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to... first patient https://www.healthday.com/infectious-disease-information-21/misc-infections-news-411/cdc-confirms-first-patient-diagnosed-with-ebola-in-united-states-692236.html CDC Confirms First Patient Diagnosed With Ebola in United States Unidentified man at Dallas hospital developed symptoms days after flying from West Africa first patientcdcconfirmsdiagnosedebola https://robbie.ai/ Advanced Vision AI for Healthcare | Privacy-First Patient Monitoring ai for healthcarefirst patientadvancedvisionprivacy https://www.prnewswire.co.uk/news-releases/first-patient-cells-collected-in-xnks-preclinical-bladder-cancer-study-301703942.html First patient cells collected in XNK's preclinical bladder cancer study /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced that the first patient has donated cells in the recently initiated preclinical evaluation of the... first patientbladder cancercellscollected https://www.finanznachrichten.de/nachrichten-2018-03/43260935-acasti-pharma-inc-acasti-pharma-announces-first-patient-randomized-in-pivotal-trilogy-phase-3-program-of-capre-in-severe-hypertriglyceridemia-256.htm Acasti Pharma Inc.: Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3... LAVAL, QUEBEC -- (Marketwired) -- 03/14/18 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST) today announced that the first patient has been randomized... first patient https://www.biospace.com/svelte-medical-systems-announces-first-patient-enrolled-in-pivotal-optimize-study Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study - BioSpace Jan 10, 2018 - The Svelte IDS and RX systems utilize low profile, highly conformable stents and a new class of bioresorbable drug carrier eluting sirolimus. medical systemsfirst patient https://www.imperial.ac.uk/research-and-innovation/support-for-staff/joint-research-office/hrs/stages/recruitmentstage/firstpatientfirstvisit/ First Patient First Visit | Research | Imperial College London The NIHR Research Support Services Framework has been developed to assist providers of NHS research in starting research more efficiently. first patientvisit researchimperial collegelondon https://www.globenewswire.com/news-release/2025/05/29/3090174/0/en/Auron-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-AUTX-703-in-Advanced-Hematologic-Malignancies.html Auron Announces First Patient Dosed in Phase 1 Clinical Novel approach targeting KAT2A/B with preclinical validation across multiple cancer models and tumor types... first patientin phaseauronannouncesdosed https://www.biospace.com/adaptive-phage-therapeutics-announces-first-patient-dosed-in-the-phage-clinical-trial-evaluating-phage-therapy-in-cystic-fibrosis-related-respiratory-infection Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial Evaluating... Jan 12, 2023 - Adaptive Phage Therapeutics, Inc., today announced the first patient has been dosed in the PHAGE clinical trial, evaluating bacteriophage therapy in adults... first patient https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-first-patient-dosed-with-evm16-its-first-internally-developed-personalized-mrna-cancer-vaccine-302394366.html Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed... The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based tumor... first patienteverestmedicinesannounces https://www.finanznachrichten.de/nachrichten-2026-03/68088273-biomea-fusion-inc-biomea-fusion-announces-first-patient-dosed-in-newly-initiated-phase-ii-programs-enrolling-type-2-diabetes-patients-failing-on-st-399.htm Biomea Fusion, Inc.: Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II... COVALENT-211 Phase II enrolling insulin-deficient type 2 diabetes patients COVALENT-212 Phase II enrolling type 2 diabetes patients uncontrolled with a GLP-1... first patient https://www.techradar.com/news/world-of-tech/this-algorithm-tracks-down-the-first-patient-in-a-disease-outbreak-1297802 This algorithm tracks down the first patient in a disease outbreak | TechRadar Jun 26, 2015 - Where the infection began the first https://www.businesswire.com/news/home/20241030676957/en/BrainTale-Announces-First-Patient-Enrolled-in-Investigator-Sponsored-Prospective-Multi-Centric-Study-CALDIFF-to-Clinically-Validate-One-of-Its-Predictive-Biomarkers BrainTale Announces First Patient Enrolled in Investigator-Sponsored Prospective Multi-Centric... BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals, announced today the enrollment of ... first patientannouncesenrolled https://www.globenewswire.com/de/news-release/2023/04/26/2655181/0/en/ContraFect-Announces-First-Patient-Dosed-in-the-Phase-1b-2-Study-of-Exebacase-in-Patients-with-Chronic-Prosthetic-Joint-Infections-of-the-Knee.html ContraFect Announces First Patient Dosed in the Phase 1b/2 YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery... first patientin thephase 1bannouncesdosed https://www.nsw.gov.au/departments-and-agencies/health-infrastructure/news/first-patient-receives-radiation-therapy-at-dubbo First patient receives radiation therapy at Dubbo | NSW Government Jun 16, 2025 - The first patient has begun life-saving radiation therapy at the new $35 million Western Cancer Centre in Dubbo. first patientradiation therapydubbo nswreceivesgovernment https://www.prnewswire.com/news-releases/biotheryx-doses-first-patient-in-phase-1-study-investigating-lead-protein-degrader-candidate-btx-1188-301468224.html BioTheryX Doses First Patient in Phase 1 Study Investigating Lead Protein Degrader Candidate... /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on developing targeted protein degraders to create life-saving medicines, today announced... phase 1 study https://stockhouse.com/news/press-releases/2025/12/09/alpha-tau-successfully-treats-first-patient-in-its-u-s-trial-for-patients-with 2025-12-09 | Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with... (2025-12-09 | NDAQ:DRTS) Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at... https://www.prnewswire.co.uk/news-releases/corneat-vision-s-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center-ending-a-decade-of-blindness-866070880.html CorNeat Vision's First Patient Regains Sight Following Artificial Cornea Implantation at Rabin... /PRNewswire/ -- The CorNeat KPro, the first artificial cornea which completely integrates with the eye wall with no reliance on donor tissue, was... https://www.biospace.com/cidara-therapeutics-doses-first-patient-in-pivotal-phase-3-respect-trial-of-rezafungin-for-prevention-of-invasive-fungal-disease-in-patients-undergoing-allogeneic-blood-and-marrow-transplantation Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for... May 20, 2020 - Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing... https://www.biospace.com/biocity-announces-the-first-patient-dosed-with-its-anti-tim-3-mab-bc3402-in-combination-with-imfinzi-for-the-treatment-of-advanced-hepatocellular-carcinoma-in-a-phase-ib-ii-trial BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with... Dec 21, 2023 - BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its anti-TIM-3 monoclonal antibody (mAb) BC3402 in combination... https://finviz.com/news/321376/ideaya-biosciences-announces-first-patient-in-for-phase-1-trial-of-ide034-a-potential-first-in-class-b7h3ptk7-bispecific-top1-adc IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential... Stock screener for investors and traders, financial visualizations. https://3dprint.com/233652/aries-l-3d-printed-spinal-device-implanted/ Aries-L Patient Specific 3D Printed Spinal Device Implanted for the First Time - 3DPrint.com |... Oct 20, 2021 - On Tuesday, January 8th, Dr. Samuel Joseph, Jr. and Dr. Andrew Moulton of Joseph Spine became the first in the world to implant the 3D printed titanium Aries-L... https://www.massgeneral.org/news/200-years-of-patient-care 200 Years of Patient Care: First Patients As part of the 200th anniversary of the first patient admission to the hospital, as well as celebrating the first time the Bulfinch Building opened its door to... years ofpatient care200firstpatients https://www.biospace.com/press-releases/ixcells-biotechnologies-selected-to-perform-the-first-pilot-in-patient-led-als-precision-medicine-effort iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine... https://www.umaryland.edu/news/archived-news/may-2026/first-maryland-patient-receives-fda-approved-sickle-cell-gene-therapy.php Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive... University of Maryland School of Medicine doctors at the University of Maryland Medical Center treat 41-year-old patient with her own genetically modified stem... https://ground.news/article/patient-registry-not-always-a-first-come-first-serve-wait-list-health-pei-clarifies Patient registry not always a first-come, first-serve wait list, Health P.E.I. clarifies Mar 19, 2024 - The person who has been on P.E.I.'s patient registry the longest won't necessarily be the next to get a family doctor, Health P.E.I. has confirmed. https://menafn.com/1110003751/FIRST-PATIENT-DOSED-IN-CITRYLLs-PHASE-IIA-TRIAL-EVALUATING-CIT-013-IN-RHEUMATOID-ARTHRITIS FIRST PATIENT DOSED IN CITRYLL's PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS https://www.thestar.com.my/news/nation/2020/02/17/first-malaysian-covid-19-patient-discharged First Malaysian Covid-19 patient discharged | The Star Feb 17, 2020 - PUTRAJAYA: The first confirmed Malaysian Covid-19 coronavirus patient has recovered from the disease and has been discharged. covid 19firstmalaysianpatientdischarged https://www.prnewswire.co.uk/news-releases/united-kingdoms-northampton-general-hospital-treats-first-prostate-cancer-patient-using-hdr-brachytherapy-as-sole-treatment-190649071.html United Kingdom's Northampton General Hospital Treats First Prostate Cancer Patient Using HDR... /PRNewswire/ -- Clinicians at Northampton General Hospital (NGH) recently used "monotherapy" HDR brachytherapy for the first time for a patient with prostate... northampton general hospital https://www.businesswire.com/news/home/20230109005062/en/Glycomine-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Study-of-GLM101-a-Potential-Treatment-for-PMM2-CDG Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment... Glycomine, Inc., today announced that the first patient has been dosed in a multi-center open-label Phase 2 study of GLM101. https://www.prnewswire.com/news-releases/south-rampart-pharma-announces-first-patient-enrolled-in-multiple-ascending-dose-portion-of-ongoing-phase-1-clinical-trial-301906230.html South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing... /PRNewswire/ -- South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the... https://www.biospace.com/kamada-announces-enrollment-of-first-patient-into-its-pivotal-phase-3-innovaate-clinical-trial-of-inhaled-aat-for-the-treatment-of-alpha-1-antitrypsin-deficiency Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of...